These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33804793)

  • 1. Cannabis, Cannabidiol Oils and Tetrahydrocannabinol-What Do Veterinarians Need to Know?
    De Briyne N; Holmes D; Sandler I; Stiles E; Szymanski D; Moody S; Neumann S; Anadón A
    Animals (Basel); 2021 Mar; 11(3):. PubMed ID: 33804793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats.
    Brutlag A; Hommerding H
    Vet Clin North Am Small Anim Pract; 2018 Nov; 48(6):1087-1102. PubMed ID: 30342565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.
    Rotolo MC; Graziano S; Pellegrini M; Corlazzoli D; Antinori L; Porcarelli L; Pichini S
    Curr Pharm Biotechnol; 2017; 18(10):821-827. PubMed ID: 29173160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America.
    Amissah RQ; Vogt NA; Chen C; Urban K; Khokhar J
    PLoS One; 2022; 17(4):e0261909. PubMed ID: 35442991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
    Niesink RJ; Rigter S; Koeter MW; Brunt TM
    Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danish dog owners' use and the perceived effect of unlicensed cannabis products in dogs.
    Holst P; Kristensen AT; Arendt ML
    PLoS One; 2024; 19(1):e0296698. PubMed ID: 38295012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dark Classics in Chemical Neuroscience: Δ
    Banister SD; Arnold JC; Connor M; Glass M; McGregor IS
    ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
    Arellano AL; Papaseit E; Romaguera A; Torrens M; Farré M
    CNS Neurol Disord Drug Targets; 2017; 16(5):554-566. PubMed ID: 28412920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
    Moldzio R; Pacher T; Krewenka C; Kranner B; Novak J; Duvigneau JC; Rausch WD
    Phytomedicine; 2012 Jun; 19(8-9):819-24. PubMed ID: 22571976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
    Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
    Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicians' Guide to Cannabidiol and Hemp Oils.
    VanDolah HJ; Bauer BA; Mauck KF
    Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Pellati F; Borgonetti V; Brighenti V; Biagi M; Benvenuti S; Corsi L
    Biomed Res Int; 2018; 2018():1691428. PubMed ID: 30627539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.